Československý transplantační kongres
 |
|
1. československý transplantační kongres 2. československý transplantační kongres |
Konferenční abstrakta 2008
Abstrakta přednášek – sekce lékařů
THE EUSTITE PROJECT: VIGILANCE AND SURVEILLANCE
1G. Spiteri, 1L. Noel, 2E. Porta, 3G. Garrido, 3M. Alvarez, 3R. Matesanz, 4S. Sullivan, 5K. Martiniere, 6A. Deguerra, 7R. de Vries, 8R. Tedder, 9P.Ljungman, 10T.Montag-Lessing, 11J.Koller, 12D.Brankov, 2C.Del Vecchio, 2F.Bariani, 2D. Fehily, 2A. Nanni Costa
1World Health Organisation, Geneva, 2Centro Nazionali Trapianti, Italy, 3Spanish National Transplant Organisation, 4Human Fertilisation and Embryology Authority, UK, 5Agence Francaise de Sécurité Sanitaire des Produit de Santé, 6Agence de la Biomédecine, 7European Hemovigilance Network, 8University College London, 9European Society for Bone Marrow Transplantation (EBMT), 10Paul Erlich Institute, Germany, 11University Hospital, Bratislava, Slovakia, 12Bulgarian Executive Agency for Transplantation
• FNsP Bratislava, Nemocnica Ružinov, Ruzinovska 6, Bratislava
A major objective of the EUSTITE project (European Union Standards and Training for the Inspection of Tissue Establishments, see www.eustite. org) is to propose common systems for definition, classification and reporting of adverse events and reactions that are consistent with similar systems in other parts of the world and to conduct a trial of the proposed system in a number of EU Member States. This Vigilance and Surveillance work is being managed by the World Health Organisation as part of a project work package led by the Spanish National Transplant Organisation.
The Vigilance and Surveillance Medical Advisory Committee (V&SMAC) includes some project partner representatives and a number of external experts leading in fields such as virology, bacteriology, haematopoietic stem cell transplantation and haemovigilance. As the project was launched, an expert in epidemiology was contracted by WHO to review existing systems for vigilance and surveillance of tissue and cell transplantation in the EU and North America.
The Vigilance and Surveillance Medical Advisory Committee (V&SMAC) includes some project partner representatives and a number of external experts leading in fields such as virology, bacteriology, haematopoietic stem cell transplantation and haemovigilance. As the project was launched, an expert in epidemiology was contracted by WHO to review existing systems for vigilance and surveillance of tissue and cell transplantation in the EU and North America.
Working together, EU competent authorities can improve safety for tissue donors and recipients by agreeing common and optimal approaches to vigilance and surveillance in the field.